Kevin Michael Cottrell
Inventor
Stats
- 9 US patents issued
- 32 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 9 US Patents Issued
- 32 US Applications Filed
- 123 Total Citation Count
- Oct 16, 2023 Most Recent Filing
- Jun 9, 2010 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 2
4 4 2 5 1 | 2010
2011 2013 2014 2016 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Cambridge, MA, US | Dec 16, 10 - Mar 18, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 23 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07D: | HETEROCYCLIC COMPOUNDS | 31 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12251387 | 2025 | Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors | 0 |
| 2024/0336,614 | 2024 | MODULATORS OF ALPHA-1 ANTITRYPSIN | 0 |
| 11813267 | 2023 | DNA-PK inhibitors | 0 |
| 2023/0339,915 | 2023 | MODULATORS OF ALPHA-1 ANTITRYPSIN | 0 |
| 2023/0277,547 | 2023 | SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.